PUBLIC CONTRACT · 2023
716/2023- Aquisição ao abrigo do(s) acordo(s)-quadro 2021/49, 2021/6, 2021/61 e 2022/40 para as Instituições do SNS
- Contract value
- €80,520.70
- Signed on
- 21 December 2023
- Procedure
- Ao abrigo de acordo-quadro (art.º 259.º)
This page lays out the fields published on Portal BASE and says when a field is unavailable. It is not an assessment of the contract's merit, legality or impact.
Record 10698469PUBLISHED DESCRIPTION
716/2023
WHO CONTRACTED
Parties involved
- Place of performance
- Portugal, Castelo Branco, Covilhã
- NUTS region
- Not stated
WHO BID
Awardee and competitors
Companies that IMPIC lists as the awardee and as competitors in this procedure.
- Awardee
- AstraZeneca - Produtos Farmacêuticos, Lda. · Tax ID 502942240
- Bidder
- LEO FARMACEUTICOS , LDA · Tax ID 503932680
- Bidder
- Fresenius Kabi Pharma Portugal, Lda. · Tax ID 504293753
- Bidder
- ABBVIE,LDA · Tax ID 510229050
HOW MUCH AND WHEN
Values and timeline
- Contract price
- €80,520.70
- Procedure base price
- €12,190,463.93
- Total effective price
- Not reported on Portal BASE
- Publication date
- 3 May 2024
- Award date
- 21 December 2023
- Signing date
- 21 December 2023
- Performance period
- 365 days
The contract price is the value agreed in the contract, not the amount paid.
HOW IT WAS CONTRACTED
Procedure and framework
- Contract type
- Aquisição de bens móveis
- Procedure type
- Ao abrigo de acordo-quadro (art.º 259.º)
- Award criterion
- Monofator
- CPV code
- 33600000-6 - Produtos farmacêuticos
- Legal basis
- Artigo 259.º do Código dos Contratos Públicos
- Regime
- Código dos Contratos Públicos (DL111-B/2017) e Lei n.º 30/2021, de 21.05
- Framework agreement
- CP 2021/6 - Medicamentos do foro oncológico e imunomoduladores
- Centralised procedure
- Yes
- Environmental criterion
- No
- Notice
- Not stated
- Procedure identifier
- 6804712
KEEP EXPLORING
Compare with other contracts
Search the same body, supplier, place or type of service to understand the context of the published index.